Ann Surg Treat Res.
2021 Apr;100(4):252. 10.4174/astr.2021.100.4.252.
CORRIGENDUM: Diagnostic model for pancreatic cancer using a multi-biomarker panel
- Affiliations
-
- 1Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
- 2Bio-MAX/N-Bio Institute, Seoul National University, Seoul, Korea
- 3Department of Statistics, Seoul National University, Seoul, Korea
- 4Department of Applied Mathematics, Sejong University, Seoul, Korea
- 5Data Labs, AI Center, SK Telecom, Seoul, Korea
- 6Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 7Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 8Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Korea
- 9Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
- 10Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 11Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 12Center for Liver Cancer, National Cancer Center, Seoul, Korea
- KMID: 2514723
- DOI: http://doi.org/10.4174/astr.2021.100.4.252
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Surveillance and Early Diagnosis of Pancreatic Cancer
- Diagnostic model for pancreatic cancer using a multi-biomarker panel
- Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
- Clinical Utility of Portal Venous Circulating Tumor Cells in Pancreatic Cancer
- Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
